ML-004 (IR)/(ER) tablet clinical trials

ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)

This study is looking at a new tablet treatment, ML-004, for autism in young people and adults. It's a follow-up study for those who have already completed a previous trial, focusing on how safe the medication is over time.